CannTrust Holdings (TSX:TRST): Buy the Dip or Jump Ship?

Should you buy CannTrust Holdings Inc. (TSX:TRST)(NYSE:CTST) amid the scandal?

Road sign warning of a risk ahead

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

CannTrust Holdings (TSX:TRST)(NYSE:CTST) has crashed by so much that it has a valuation that’s not cringe-worthy. Even after a +80% fall over the illicit cannabis-growth fiasco, the stock isn’t exactly what you’d consider cheap, but as far as cannabis stocks are concerned, it’s the closest thing you’ll find to a steal.

While CannTrust may be subject to penalties, I think the decline is excessive. If it were any industry other than cannabis, the fall probably would have been capped at a 40% drop. So, in essence, the recent nosediving in shares may prove to be a massive bargain in a year or two down the road, when everybody has forgotten about CannTrust’s illicit cannabis cultivation in an unlicensed room.

While CannTrust is still a speculative bet, I think there are significant rewards for those willing to take the risk.

Jefferies pointed out that a major management shuffle may be on the horizon, which would likely improve the odds that CannTrust won’t get its licence ripped up by Health Canada amid its sales suspension.

At the time of writing, the company is under a Health Canada investigation that’s expected to “conclude within a few days” with “appropriate actions [taken] immediately after.”

There’s no question that CannTrust will be a major double-digit mover in the week ahead, and although things seem dire, it’s noteworthy that most investors have been acting on speculation, not facts, as fellow Fool contributor David Jagielski pointed out in his piece on the CannTrust fiasco: “Many people have been jumping to conclusions and speculating on what may or may not happen, which has just made matters worse for the stock, as there’s nothing like mass panic to send a stock into a tailspin.”

An everything-or-nothing scenario

Depending on what Health Canada decides to do, CannTrust could either skyrocket into the stratosphere or move closer to zero.

If CannTrust has its licence suspended, there will be much more selling, and you’ll probably lose your entire investment in the name. In any other scenario, CannTrust could be a quick triple, especially if there are only fines, firings, and corrective actions involved.

In any case, I think that management has learned their lesson the hard way. I suspect the company will face a soured upcoming quarter, but I don’t think the company will be left for dead — a scenario many investors seem to be buying into. After its +80% plunge, I’d say the lousy quarter is baked in many times over.

Furthermore, Jagielski brought up a good point in that the government wants the industry to succeed, and a licence suspension, which could stunt investment across the broader industry, is not a reasonable course of action.

I think CannTrust is a solid buy on the dip but only for those with excess cash that they wouldn’t mind losing entirely.

Stay hungry. Stay Foolish.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »